当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2011年第33期 > 正文
编号:12149288
盐酸左西替利嗪片溶出度测定条件的研究(1)
http://www.100md.com 2011年11月25日 赵辉 吴燕 刘丽平 张福成
第1页

    参见附件(2288KB,3页)。

     [摘要] 目的:摸索盐酸左西替利嗪片体外溶出度测定条件。方法:依据《中国药典》2010年版和有关的参考文献,采用正交试验,考察溶出介质(0.1 mol/L盐酸溶液、pH 6.8的磷酸盐缓冲液及水)、转速(50、75、100 r/min)、取样时间(5、15、30 min)三个因素对盐酸左西替利嗪片体外溶出度测定的影响,采用紫外分光光度法,在230 nm波长下测定吸光度并计算溶出度。结果:盐酸左西替利嗪检测浓度为2~10 μg/ml(r=0.999 8),平均回收率为99.98%,RSD=0.28%;选择桨法,以水为溶出介质,转速为75 r/min,取样时间点为30 min是盐酸左西替利嗪片溶出度测定条件。结论:本法简便、可靠、准确,适合盐酸左西替利嗪片溶出度的测定。

    [关键词] 盐酸左西替利嗪片;溶出度;正交试验;紫外分光光度法

    [中图分类号] R917 [文献标识码] A [文章编号] 1673-7210(2011)11(c)-034-03

    Conditions test of Levocetirizine Dihydrochloride Tablets dissolution

    ZHAO Hui, WU Yan, LIU Liping, ZHANG Fucheng

    Department of Pharmacy, General Hospital of Air Force, Beijing 100142, China

    [Abstract] Objective: To explore the conditions test of Levocetirizine Dihydrochloride Tablets dissolution in vitro. Methods: According to the methods of Chinese Pharmacopoeia (2010 edition) and other references, the influence to the dissolution conditions of Levocetirizine Dihydrochloride Tablets, such as dissolution mediums (0.1 mol/L hydrochloric acid solution, pH 6.8 phosphate buffer solution, water as medium), rotation speeds (50, 75, 100 r/min), and sampling time (5, 15, 30 min) were investigated by orthogonal experiment. The absorbance and release rate of solution were determined by UV spectrophotometry at 230 nm. Results: The assay displayed a good linearity over the concentration range of 2-10 μg/ml (r=0.999 8) with an average recovery was 99.98% (RSD=0.28%). Paddle method was adopted by using water as the solvent, and the rotation speed at 75 r/min with sampling time was 30 min. Conclusion: The method is simple, reliable and accurate, and it can be applied to determine dissolution of Levocetirizine Dihydrochloride Tablets.

    [Key words] Levocetirizine Dihydrochloride Tablets; Dissolution; Orthogonal experiment; UV spectrophotometry

    过敏性疾病是一种常见病、多发病,药物治疗是控制过敏反应的主要手段,目前临床上常用H1受体拮抗剂。盐酸左西替利嗪片作为新型抗组胺药,具有口服吸收迅速、受体选择性高、临床疗效强、副作用小、安全性好等多方面优点[1-2],是治疗过敏性疾病的首选药物。本文采用正交试验,对溶出介质、转速及取样时间点3个影响因素进行考察,建立了适宜的溶出方法,并采用紫外分光光度法测定体外溶出度,为产品的质量控制提供依据。

    1 仪器与试药 ......

您现在查看是摘要介绍页,详见PDF附件(2288KB,3页)